Testing of Czech anti-cancer drug proves highly successful

Initial tests of a new Czech anti-cancer drug –known as GS-9219 – have proved highly successful on animals. The drug against lymphatic cancer has been tested on dogs with what doctors call startling results. The dogs were cured within five days of getting the first doze. Gilead Sciences, which will produce the medicine, is testing the product in five top institutes in the US and another five facilities in the Czech Republic. Still doctors have warned against premature optimism since it is not yet clear how humans will react to the drug. GS 92 19 kills tumour cells without harming healthy tissue. If tests on humans are successful the drug could be on the market within six to eight years.